One-Shot gene therapy could free men from bleeding disorder
Disease control
Recruiting now
This study is testing a one-time gene therapy injection for men with hemophilia A, a serious bleeding disorder. The therapy aims to help the liver produce the missing clotting factor, which could significantly reduce or prevent bleeding episodes. The trial will follow 50 Chinese …
Phase: PHASE3 • Sponsor: Gritgen Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC